Up a level |
Malaba, Thokozile R, Nakatudde, Irene, Kintu, Kenneth, Colbers, Angela, Chen, Tao ORCID: 0000-0002-5489-6450, Reynolds, Helen ORCID: 0000-0001-7443-4520, Read, Lucy, Read, Jim, Stemmet, Lee-Ann, Mrubata, Megan et al (show 18 more authors)
(2022)
72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study.
LANCET HIV, 9 (8).
E534-E543.
Griffiths, Gareth O, FitzGerald, Richard, Jaki, Thomas, Corkhill, Andrea, Reynolds, Helen ORCID: 0000-0001-7443-4520, Ewings, Sean, Condie, Susannah, Tilt, Emma, Johnson, Lucy, Radford, Mike et al (show 27 more authors)
(2021)
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter.
TRIALS, 22 (1).
487-.
Challenger, Elizabeth ORCID: 0000-0002-8978-6067, Penchala, Sujan Dilly, Hale, Colin, Fitzgerald, Richard, Walker, Lauren ORCID: 0000-0002-3827-4387, Reynolds, Helen ORCID: 0000-0001-7443-4520, Chiong, Justin, Fletcher, Tom, Khoo, Saye and Else, Laura
(2023)
Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 233.
115436-.
Walimbwa, Stephen I, Lamorde, Mohammed, Waitt, Catriona ORCID: 0000-0003-0134-5855, Kaboggoza, Julian ORCID: 0000-0001-9510-0474, Else, Laura, Byakika-Kibwika, Pauline, Amara, Alieu ORCID: 0000-0002-1137-2948, Gini, Joshua, Winterberg, Markus, Chiong, Justin ORCID: 0000-0001-8063-6399 et al (show 2 more authors)
(2019)
Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63 (2).
e01310-e01318.
Reynolds, Helen E, Chrdle, Ales, Egan, Deirdre, Chaponda, Mas, Else, Laura, Chiong, Justin ORCID: 0000-0001-8063-6399, Back, David J and Khoo, Saye H
(2015)
Effect of intermittent rifampicin on the pharmacokinetics and safety of raltegravir.
The Journal of antimicrobial chemotherapy, 70 (2).
pp. 550-554.
Ayuso, Pedro, Neary, Megan ORCID: 0000-0002-4960-2139, Chiong, Justin ORCID: 0000-0001-8063-6399 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2019)
Meta-analysis of the effect of <i>CYP2B6, CYP2A6, UGT2B7</i> and <i>CAR</i> polymorphisms on efavirenz plasma concentrations.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 74 (11).
pp. 3281-3290.
Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Flexner, Charles, Chiong, Justin ORCID: 0000-0001-8063-6399, Owen, Andrew ORCID: 0000-0002-9819-7651, Donnelly, Ryan F, Larraneta, Eneko and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2019)
Modelling the intradermal delivery of microneedle array patches for long-acting antiretrovirals using PBPK.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 144.
pp. 101-109.
Khoo, Saye H ORCID: 0000-0002-2769-0967, FitzGerald, Richard, Saunders, Geoffrey, Middleton, Calley, Ahmad, Shazaad, Edwards, Christopher J, Hadjiyiannakis, Dennis, Walker, Lauren ORCID: 0000-0002-3827-4387, Lyon, Rebecca, Shaw, Victoria ORCID: 0000-0002-0429-0186 et al (show 80 more authors)
(2022)
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial.
The Lancet Infectious Diseases, 23 (2).
pp. 183-195.
Khoo, Saye H ORCID: 0000-0002-2769-0967, Fitzgerald, Richard, Fletcher, Thomas, Ewings, Sean, Jaki, Thomas, Lyon, Rebecca, Downs, Nichola, Walker, Lauren ORCID: 0000-0002-3827-4387, Tansley-Hancock, Olana, Greenhalf, William et al (show 28 more authors)
(2021)
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76 (12).
pp. 3286-3295.
Rajoli, Rajith KR ORCID: 0000-0002-6015-5712, Curley, Paul ORCID: 0000-0003-4596-2708, Chiong, Justin ORCID: 0000-0001-8063-6399, Back, David, Flexner, Charles, Owen, Andrew ORCID: 0000-0002-9819-7651 and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2019)
Predicting Drug-Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling.
JOURNAL OF INFECTIOUS DISEASES, 219 (11).
pp. 1735-1742.